Browsing by Subject "Forschung und Entwicklung"
Now showing 1 - 7 of 7
- Results Per Page
- Sort Options
Publication Corporate taxation and the quality of research and development(2013) Riedel, Nadine; Richter, Katharina; Ernst, ChristofThis paper examines the impact of tax incentives on corporate research and development (R&D) activity. Traditionally, R&D tax incentives have been provided in the form of special tax allowances and tax credits. In recent years, several countries moreover reduced their income tax rates on R&D output. Previous papers have shown that all three tax instruments are effective in raising the quantity of R&D related activity. We provide evidence that, beyond this quantity effect, corporate taxation also distorts the quality of R&D projects, i.e. their innovativeness and revenue potential. Using rich data on corporate patent applications to the European patent office, we find that a low tax rate on patent income is instrumental in attracting innovative projects with a high earnings potential and innovation level. The effect is statistically significant and economically relevant and prevails in a number of sensitivity checks. R&D tax credits and tax allowances are in turn not found to exert a statistically significant impact on project quality.Publication Endogenous life expectancy and R&D-based economic growth(2021) Tscheuschner, PaulWe propose an overlapping generations framework in which life expectancyis determined endogenously by governmental health investments. As a nov-elty, we are able to examine the feedback effects between life expectancy andR&D-driven economic growth for the transitional dynamics. We find that i)higher survival induces economic growth through higher savings and higherlabor force participation; ii) longevity-induced reductions in fertility hampereconomic development; iii) the positive life expectancy effects of larger savingsand higher labor force participation outweigh the negative effect of a reductionin fertility, and iv) there exists a growth-maximizing size of the health caresector that might lie beyond what is observed in most countries. Altogether,the results support a rather optimistic view on the relationship between lifeexpectancy and economic growth and contribute to the debate surroundingrising health shares and economic development.Publication Inter-firm R&D networks in pharmaceutical biotechnology : what determines firm's centrality-based partnering capability?(2013) Schwalbe, Ulrich; Riedel, Nadine; Krogmann, YinThis paper analyses the inter-firm R&D network formed in the pharmaceutical biotechnology industry during the 1990s from different perspectives: theoretical network formation, firm's structural positions and its collaborations at the entire network level, and the determinants for firm's centrality-based partnering capability. The results indicate that pharmaceutical biotechnology industry has experienced a significant evolutional change in size and structure during 1991-1998. By considering individual structural positions, the descriptive statistics show that in the 1990s, established pharmaceutical companies developed into dominant star players with multiple partnerships while holding central roles in the R&D network. In the network analysis that emphasized aggregate network level, the degree-based and betweenness-based network centralization were not high implying that the distribution of overall positional advantages in the pharmaceutical biotechnology industry is, to a large degree, not unequal and even though most firms in this sector are linked to the R&D network, some of them are more active than others. The current analysis also shows that firm's efficiency, firm's dependency on its complementary resources and firm's experiences at managing partnerships are important determinants for firm's centrality-based partnering capability, which has important managerial implications for understanding firm's strategic partnering behaviour.Publication Inter-firm R&D networks in the global pharmaceutical biotechnology industry during 1985?1998 : a conceptual and empirical analysis(2011) Krogmann, Yin; Schwalbe, UlrichThis paper analyses a large database on inter-firm R&D cooperation formed in the pharmaceutical biotechnology industry during the period 1985?1998. The results indicate that network size largely grows, whereas the density of the network declines during the periods. In the network analysis that emphasizes individual structural positions, the empirical results show that small biotechnological companies had a crucial bridging role for the large pharmaceutical firms in the second half of the 1980s. In the 1990s, the bridge role of biotechnology companies became less important and established pharmaceutical companies developed into dominant start players with many collaborators while holding central roles in the research network. The current analysis also shows that degree-based and betweenness-based network centralization are both low implying that the overall positional advantages are relatively equally distributed in the inter-firm R&D network of the pharmaceutical biotechnology industry.Publication Network evolution, success, and regional development in the European aerospace industry(2014) Barber, Michael J.; Guffarth, DanielThe success breeds success hypothesis has been mainly applied to theoretical network approaches. We investigate the European aerospace industry using data on the European Framework Programmes and on Airbus suppliers, focusing on the success breeds success hypothesis at four levels of analysis: the spatial structure of the European aerospace R&D collaboration network, its topological architecture, the individual actors that make up the network, and through a comparison of the Airbus invention and production networks. On the spatial level, SBS is favored: successful regions maintain their position and grow on a large scale, especially so for regions that have strongly participated from the very beginning. The regional hub structure is mirrored in the architecture of the European aerospace R&D collaboration network, where well-connected hub organizations play a key role in shaping the structure of the network through their many collaborative partnerships and do so in a way that strategically positions themselves with greater ability to access and regulate knowledge flows, as assessed by several centrality measures. Only successful organizations have the ability to form so many ties, with success thus breeding success in the European aerospace R&D collaboration network. The importance of the core organizations made clear through the centrality analysis is further supported by the analysis of weak ties, where we observe that the core organizations are connected to the rest of the network with many weak ties, thereby confirming their outstanding positions in the European aerospace R&D collaboration network as being able to access knowledge or other resources. With the combination of the R&D collaboration network and the Airbus production network on a spatial level, we see additional support for SBS, as those regions whose actors are frequent participants in both networks show the greatest share of successful actors. The European aerospace industry shows an ambidextrous character as a whole, which is nonetheless insufficient to avoid recent and future challenges demanding a strong emphasis on production skills.Publication The European aerospace R&D collaboration network(2013) Barber, Michael J.; Guffarth, DanielWe describe the development of the European aerospace R&D collaboration network from 1987 to 2013 with the help of the publicly available raw data of the European Framework Programmes and the German Förderkatalog. In line with the sectoral innovation system approach, we describe the evolution of the aerospace R&D network on three levels. First, based on their thematic categories, all projects are inspected and the development of technology used over time is described. Second, the composition of the aerospace R&D network concerning organization type, project composition and the special role of SMEs is analyzed. Third, the geographical distribution is shown on the technological side as well as on the actor level. A more complete view of the European funding structure is achieved by replicating the procedure on the European level to the national level, in our case Germany.Publication Turkish-German innovation networks in the European research landscape(2013) Heller-Schuh, Barbara; Pyka, Andreas; Prostolupow, IreneResearch networks are regarded as channels for knowledge creation and diffusion and are thus essential for the development and integration of economies. In this paper we have a look at the long Turkish-German-migration history which should offer opportunities for both countries to benefit from brain circulation, transnational entrepreneurs and research networks. The present paper examines the structure of research networks of the European Framework Programmes (FP) that are established by joint participation of organizations in research projects, in particular German research organizations with Turkish participants in FP5 to FP7 in the knowledge-intensive technology fields ICT, Biotechnology and Nanoscience. A better understanding of these networks allows for improving the design of research policies at national levels as well as at the EU level. The empirical examination of network properties reveals that the diverse networks show a range of similarities in the three technology fields in each FP such as the small-world properties. Moreover, our findings show that German actors play a specific role in most examined research networks with Turkish participation.